key: cord-0712673-em71jn3h
authors: Nyazika, Tinashe K.; Law, Alice; Swarthout, Todd D.; Sibale, Lusako; ter Braake, Danielle; French, Neil; Heyderman, Robert S.; Everett, Dean; Kadioglu, Aras; Jambo, Kondwani C.; Neill, Daniel R.
title: Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.
date: 2020-07-22
journal: J Infect
DOI: 10.1016/j.jinf.2020.06.079
sha: 1e69293389ef4067388823669c77baa298b4bc03
doc_id: 712673
cord_uid: em71jn3h

BACKGROUND: High pneumococcal carriage density is a risk factor for invasive pneumococcal disease (IPD) and transmission, but factors that increase pneumococcal carriage density are still unclear. METHODS: We undertook a cross-sectional study to evaluate the microbial composition, cytokine levels and pneumococcal carriage densities in samples from children presenting with an influenza-like illness (ILI) and asymptomatic healthy controls (HC). RESULTS: The proportion of children harbouring viral organisms (Relative risk (RR) 1.4, p=0.0222) or ≥4 microbes at a time (RR 1.9, p<0.0001), was higher in ILI patients than HC. ILI patients had higher IL-8 levels in nasal aspirates than HC (median [IQR], 265.7 [0 – 452.3] vs. 0 [0 – 127.3] pg/ml; p = 0.0154). Having an ILI was associated with higher pneumococcal carriage densities compared to HC (RR 4.2, p<0.0001). CONCLUSION: These findings suggest that children with an ILI have an increased propensity for high pneumococcal carriage density. This could in part contribute to increased susceptibility to IPD and transmission in the community.

Pneumococcal carriage is a prerequisite for disease and an important step for transmission. In Malawi, pneumococcus is known to be the major cause of meningitis and second cause of bacteraemia and community acquired pneumonia [1] [2] [3] [4] [5] . The majority of invasive pneumococcal disease (IPD) cases are seen in children under the ages of 5 and carriage rates are known to increase with age between 0 to 5yrs [6] [7] [8] . IPD cases have been shown to be on the decrease in Africa, including Malawi with uptake of the PCV 9,10 .

Pneumococcal meningitis frequently seen in those between the ages of 6 -18 months, while bacteraemia is commonly seen amongst those aged 6 -36 months and pneumococcal pneumonia occurring in children between 3 -60 months of age 9, 11 . In Malawi, pneumococcal disease peaks during the colder and drier months, with serotypes 1, 6A/B, 14 and 23F being major causes of IPD in children 1, 5, [12] [13] [14] .

Pneumococcal carriage is common in children, with approximately 80% of underfives in Malawi carrying at a given time 15 , and is influenced by the microbial composition of the upper respiratory tract (URT), including viral co-infections [16] [17] [18] [19] [20] [21] . Colonisation studies have demonstrated that microbe-microbe competition and synergy occur in the URT 18, 22, 23 .

For example, strong positive associations of pneumococcal nasopharyngeal carriage with rhinovirus, influenza virus, respiratory syncytial virus (RSV) and parainfluenza virus have been reported [24] [25] [26] . Viral-induced local inflammation in the nasal mucosa has been implicated as an important factor that promotes pneumococcal carriage and transmission [27] [28] [29] . Respiratory viral infections are associated with increased pneumococcal carriage density 25, 27, [30] [31] [32] .

Specifically, a direct correlation between heightened mucosal inflammation and high pneumococcal carriage density has been reported in children with RSV infection 27 .

Inflammation in the nasal mucosa drives epithelial denudation, up-regulation of platelet-activating factor receptor (PAFr) and polymeric immunoglobulin receptor (pIgR) on epithelial cells, resulting in increased adherence of pneumococci and evasion of the nasal mucosal surface [33] [34] [35] [36] . These observations highlight the important association, clinical and epidemiological, between virally induced inflammation in the URT and the pneumococcus.

Influenza-like illness (ILI) is prevalent amongst children [37] [38] [39] , with respiratory viral and bacterial pathogens reported as the key etiological agents 40, 41 . Recognising that ILI is common in Malawi and that the aetiology of ILI induces inflammation which increases both risk of carriage and carriage density, we hypothesised that children with an influenza-like illness (ILI) residing in Malawi, are more likely to harbour higher pneumococcal carriage densities than asymptomatic healthy controls. We conducted a cross-sectional study in children, recruiting those with and without ILI symptoms. Here, we show that children with an ILI harboured more respiratory microbes per individual, exhibited higher levels of IL-8 in the nasal mucosa, and had increased likelihood of high pneumococcal carriage densities, than asymptomatic healthy controls. These findings have potential broader implications in the development of interventions to curb pneumococcal disease and transmission.

HIV-uninfected children were recruited into a comparative cross-sectional study from the Gateway clinic, a government primary healthcare facility and surrounding communities, between June and September 2017. All participants were from within Blantyre, a commercial city in the southern part of Malawi. Children between the ages of 1 and 10 years were conveniently sampled into two groups; children fulfilling the WHO influenza-like-illness (ILI) case definitions and community asymptomatic healthy controls. ILI was defined as having an acute respiratory illness (ARI) of recent onset (within 10 days of screening) manifested by fever (≥38.0°C), cough but not requiring hospitalisation 42 . We excluded participants that had received antibiotics at least 14-days prior to recruitment into the study.

HIV status was confirmed using a single rapid test kit, STAT-VIEW HIV 1/2 assay (ChemBio Diagnostic Systems Inc, USA), and willingness to test was part of the inclusion criteria. Written informed consent were obtained from parents/guardians for children under the age of 8 and assents for children aged 8 and above. Ethical approval was obtained from the local ethics committee COMREC (P.07/ 16/1990 ) and University of Liverpool 

A nylon nasal swab (FLOQSwabs TM , Copan Diagnostics, USA) was inserted into the nostril to the nasopharynx, a depth equal to the outer ear and left in place for 2-3 seconds before slow removal with a rotating movement. Two different swabs were used to sample both nares, using the same method. The swabs were placed in 1 ml skim milk-tryptoneglucose-glycerol (STGG) media and transported to the Malawi-Liverpool-Wellcome Trust laboratories for processing.

Nasopharyngeal secretions were aspirated through a disposable sterile catheter connected to a mucus trap and vacuum source. The catheter was inserted into a nostril, directed posteriorly and toward the opening of the external ear to allow extraction from the nasopharynx. Suction (100-120mmHg for children; 120-150mmHg for adults) was applied whilst the catheter was slowly withdrawn using a rotating motion. Mucus from the other nostril was collected with the same catheter, using the same method. After mucus collection from both nostrils, the catheter was flushed with 2 ml sterile phosphate buffered saline.

Mucus aspirates were vortexed, aliquoted and frozen at -80˚C within 1-hour of collection.

Nasopharyngeal (NP) swabs, after collection and prior to initial freezing, were vortexed and 100µl of the suspension cultured on sheep blood agar with gentamicin (SBG;

7% sheep blood agar, 5 µL gentamicin/mL) overnight at 37°C and 5% CO 2. Plates showing no S. pneumoniae growth were incubated for a further 24-hours before being reported as negative. S. pneumoniae was identified by colony morphology and optochin disc (Oxoid, Basingstoke, UK) susceptibility and bile solubility test was done on isolates with zone diameter <14mm. Nasopharyngeal pneumococcal carriage was detected via qPCR, targeting S. pneumoniae virulence gene lytA and semi-quantitative microbiological culture (Miles and Misra), which was positively correlated with regards to detection and density determination and has been shown previously 43 . Samples were classified as positive for pneumococci by the presence of growth by culture and/or if lytA qPCR signals were >10 DNA copies, <40 cycles.

Total nucleic acids were extracted from 300µl aliquots of the nasal aspirate by manual promoter fused to the firefly luciferase reporter gene. MLEC cells were cultured, and TGF- quantified from aspirates, as previously described 44, 45 .

We performed statistical analyses and graphical presentation using GraphPad Prism 8 (GraphPad Software, USA). Statistically significant differences between groups were determined using the Mann-Whitney U test, and the data is summarised as median with interquartile ranges (IQR). Categorical data were summarised as proportions and compared using the Fisher's exact test, with effect size reported as Relative Risk.

A total of 47 HIV-uninfected children were recruited, comprising of 21 asymptomatic healthy children and 26 influenza-like illness outpatients ( Table 1 ). The asymptomatic healthy controls were predominantly female (71.4%), while those with an influenza-like illness were predominantly male (75.0%). Furthermore, the ILI group was relatively younger (1 -4yrs, 80.8 vs. 47.6%, p=0.029), and the age eligible children were more likely to have received the 13-valent pneumococcal conjugate vaccine (PCV13) (84.6 vs. 52.4%, p=0.025).

PCV13 was rolled out in Malawi in 2011.

Using an FTD multiplex real-time PCR, we detected viruses, bacteria and fungi in the nasal aspirates among the ILIs and asymptomatic healthy controls ( Figure 1A) . ILI patients were more likely than healthy controls to have a virus in their nasal aspirate (Relative risk (RR), 1.4 [95% CI 1.069-1.953], p=0.0222). The prevalence of ILI-associated pathogens including influenza virus, human rhinovirus and enterovirus was 11.5%, 11.5% and 23% in ILI patients, and 4.7%, 4.7% and 14.3% in healthy controls, respectively. Furthermore, ILI patients were more likely to have greater than four microbes per individual compared to the asymptomatic healthy controls (RR, 1.9 [95% CI 1.427-2.395], p<0.0001) ( Figure 1B) . These findings suggest that children with ILI are not only more likely to harbour a viral organism but also multiple respiratory microbes within the nasal mucosa.

Having established that an ILI is associated with increased likelihood of detecting a viral organism and/or multiple microbes, we investigated the cytokine microenvironment in the upper respiratory tract (URT) by measuring the levels of pro-and anti-inflammatory cytokines in nasal aspirates of ILI patients and healthy controls. The levels of proinflammatory cytokine IL-8 were higher in nasal aspirates from children presenting with ILI, (Figure 2A) . Furthermore, children with ILI were more likely to have detectable IL-8 than asymptomatic healthy controls (RR, 1.9 [95% CI 1.46 -2.72], p<0.0001). In contrast, the levels of IFN-γ, IL-10 and active TGF-β in nasal aspirates were similar between children presenting with ILI and healthy controls (all p>0.05; Figure 2B -D). Collectively, these findings suggest that children presenting with ILI likely have ongoing URT inflammation.

Following observations that ILI patients were likely to have an inflamed URT mucosa, we determined whether this could impact pneumococcal carriage dynamics.

Combining the pneumococcal carriage detection data from culture and lytA PCR on NP swabs the prevalence of carriage was higher in ILI patients than asymptomatic healthy controls (84.6 vs. 57.1%, p=0.037) ( Figure 3A ). There was a strong concordance between culture and lytA PCR (Sensitivity 0.9310, Specificity 0.7647) ( Table 2) . The difference in prevalence between the two groups is likely due to age differences 46 , however the ages of carriage positives were similar in both groups (median, range; 2 (1-9) vs. 3 (1 -9), p=0.4476).

There was also no difference in median bacterial density between ILI patients and asymptomatic healthy controls (3.24 [2.23 -3.50] vs 3.89 [3.06 -4.37] ; p=0.1115) ( Figure   3B ). There was a strong correlation between pneumococcal density as measured by lytA PCR and culture (r=0.6800, p<0.0001) (Supplementary Figure 1) . However, further analysis revealed that children with ILI were more likely to harbour bacterial densities of ≥10 4 cfu/ml than asymptomatic healthy controls (RR, 4.2 [95% CI 2.396 -7.919], p<0.0001) ( Figure 3C ).

Taken together, these findings suggest that having an ILI is associated with increased propensity for high pneumococcal carriage density.

This study describes the relationship between having an influenza-like illness (ILI) in children and pneumococcal carriage. Pneumococcus is the leading cause of pneumonia and invasive bacterial infections in all ages, with the greatest incidence being in children under the age of 5 [47] [48] [49] . In this study, ILI patients had higher likelihood of greater pneumococcal carriage densities than asymptomatic healthy controls. This is consistent with studies that have shown that viral infection driven local inflammation in the nasal mucosa is associated with increased pneumococcal carriage load [25] [26] [27] 29, 31 . In line with the role of IL-8 in maintaining an inflammatory microenvironment at the site of infection 50 , having an ILI was associated with high levels of IL-8. Inflammation leads to increased adherence of pneumococci to the nasal mucosal surface 33, 51 , but also clearance of pneumococci from the URT 52 . Recent work from the experimental human challenge model has demonstrated that prior nasal infection with live attenuated influenza virus (LAIV) induces inflammation and impairs innate immune function, leading to increased pneumococcal carriage densities 29 . It is therefore plausible that local inflammation in the URT during an ILI episode promotes a conducive environment for pneumococcal survival and replication.

On the other hand, the high pneumococcal carriage density could be one of the aetiological factors for the development of an influenza-like illness. ILI in this study was defined by clinical presentation, following the WHO guidelines 42 . It is well known that ILI may be caused by both viral and bacterial infections, of which S. pneumoniae is a potential aetiological agent 40 . In our cohort, we observed a high propensity for respiratory viral organisms in the ILI patients compared to healthy controls. One of the common pathogens associated with ILI is influenza virus 37, 53 . The prevalence of influenza virus in the patients with ILI was 11.5%, and this is consistent with previous studies in Malawi that reported influenza prevalence between 8.3% to 13.7% among patients with severe acute respiratory illness (SARI) and community cases of ILI 54, 55 . The ILI patients were more likely to have harbour more than four potentially pathogenic respiratory organisms per individual in their nasal aspirate compared to healthy controls. This highlights the complexity of identifying the underlying infective aetiology of ILI in children in high transmission and disease-burdened settings.

Nevertheless, the lack of data on the definitive aetiological agents in our ILI patients constitutes a study limitation. It is clear from our study and others 40, 56, 57 that the majority of ILI cases likely not caused by influenza but by other viruses or bacteria. Defining the aetiology of ILI in children in high transmission and disease-burdened settings like Malawi should be a research priority, as it could help in development of potential interventions to curb transmission of potentially pathogenic respiratory organisms in the community. The other limitation of study is the imbalance in our two study groups in terms of age and gender, which potentially skewed our pneumococcal carriage prevalence data. However, pneumococcal carriage density was unlikely impacted by age in our study, since the median age of the carriage positive children was similar between the two groups. Furthermore, we found similar carriage rates among the PCV-13 age eligible children, but we were not able to serotype the pneumococcus in order to elucidate its impact on vaccine serotypes. Unexpectedly, we found relatively high prevalence of other pathogens, including notably Salmonella and pneumocystis jirovecii. For the bacterial genus Salmonella, we were not able to identify the organisms to species level in order to differentiate between pathogenic and commensal organisms. In Malawi, at least 10.3% of bloodstream infections have been reported to be caused by S. typhi 58 . Whilst, Pneumocystis jirovecii is estimated between 6.8 -51%, to be the causative agent of children presenting with acute lower respiratory infection in Africa [59] [60] [61] [62] .

In conclusion, we have demonstrated that having an ILI is associated with increased propensity for high pneumococcal carriage density in children. These findings have potential implications in the development of interventions to curb pneumococcal disease and transmission, since high-density pneumococcal carriage is an important risk factor for pneumonia and transmission. 

Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi

Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type B vaccination

Etiology and risk factors for mortality in an adult community-acquired pneumonia cohort in Malawi

The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection

HIV infection and the epidemiology of invasive pneumococcal disease (IPD) in South African adults and older children prior to the introduction of a pneumococcal conjugate vaccine (PCV)

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000-2019: protocol for systematic review

The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review

Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines

High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease

Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi

Microbial composition of the human nasopharynx varies according to influenza virus type and vaccination status

The microbiome of the upper respiratory tract in health and disease

de Steenhuijsen Piters WAA, Sanders EAM, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease

Streptococcus pneumoniae colonization disrupts the microbial community within the upper respiratory tract of aging mice

Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination

Bacterial competition: surviving and thriving in the microbial jungle

Influence of bacterial interactions on pneumococcal colonization of the nasopharynx

The Role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children

Nasopharyngeal pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness

High pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants

Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

Pneumococcal carriage, density, and co-colonization dynamics: A longitudinal study in Indonesian infants

High Nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia

Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children

The immunological mechanisms that control pneumococcal carriage

Cross-reactivity of antiPneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC

The Effects of secretory IgA in the mucosal immune system

Choline binding proteins from Streptococcus pneumoniae: A dual role as enzybiotics and targets for the design of new antimicrobials

Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR': A prospective, community-based cohort study

Epidemiology of influenza-like Illness during pandemic (H1N1)

Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh

Influenza-like illness in residential care homes: a study of the incidence, aetiological agents, natural history and health resource utilisation

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample

Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection

Density and duration of experimental human pneumococcal carriage

An assay for Transforming Growth Factor-Beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct

Density and duration of pneumococcal carriage is maintained by Transforming Growth Factor β1 and T regulatory cells

Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage

Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination? Hum Vaccines Immunother

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study

Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15

Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface

Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model

Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems

Respiratory virus-associated severe acute respiratory illness and viral clustering in Malawian children in a setting with a high prevalence of HIV infection, malaria, and malnutrition

Impact of human immunodeficiency virus on the burden and severity of influenza illness in Malawian adults: a prospective cohort and parallel case-control study

Viral and bacterial etiologies of acute respiratory infections among children under 5 years in

Upper respiratory tract bacteria in Influenza-like illness cases in Indonesia using multiplex PCR method

Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study

High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia

Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children

Pneumocystis pneumonia in South African children diagnosed by molecular methods

Current epidemiology of Pneumocystis pneumonia

The authors thank all study participants, the clinical team (Mrs Mercy Juma, Mr Andrew Sigoloti, Ms Chifundo Kondoni) and supporting staff of Malawi-Liverpool-Wellcome Trust Clinical Research Programme and Queen Elizabeth Central Hospital for their support and cooperation during the study.

We declare no competing interests.